{"slideshow_credits": null, "snippet": "The company reported net income of $781 million, or 26 cents a share, down from $908 million, or 30 cents a share, a year earlier.", "abstract": "Merck forms alliance with Amgen, Incyte and Pfizer to test its experimental cancer drug; reports fourth-quarter profit of $731 million, or 26 cents a share, down 14 percent from $908 million, or 30 cents a share, in year-ago quarter; revenue was $2.6 billion.", "section_name": "Business Day", "print_page": "8", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/02/06/business/profit-drops-14-at-merck-just-below-wall-st-forecast.html", "lead_paragraph": "The company reported net income of $781 million, or 26 cents a share, down from $908 million, or 30 cents a share, a year earlier.", "headline": {"main": "Profit Drops 14% at Merck, Just Below Wall St. Forecast", "print_headline": "Merck Forms Cancer Drug Alliance With 3 Firms", "content_kicker": "Business Briefing"}, "_id": "52f2e2e738f0d814439d9255", "word_count": "114", "multimedia": [], "pub_date": "2014-02-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Pfizer Inc", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Company Reports", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Amgen Inc", "name": "organizations", "is_major": "N", "rank": "6"}, {"value": "Incyte Corporation", "name": "organizations", "is_major": "N", "rank": "7"}, {"value": "Cancer", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Merck & Company Inc", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}